%0 Journal Article
%T ASCT2 is a major contributor to serine uptake in cancer cells.
%A Conger KO
%A Chidley C
%A Ozgurses ME
%A Zhao H
%A Kim Y
%A Semina SE
%A Burns P
%A Rawat V
%A Lietuvninkas L
%A Sheldon R
%A Ben-Sahra I
%A Frasor J
%A Sorger PK
%A DeNicola GM
%A Coloff JL
%J Cell Rep
%V 43
%N 8
%D 2024 Aug 27
%M 39068660
暂无%R 10.1016/j.celrep.2024.114552
%X The non-essential amino acid serine is a critical nutrient for cancer cells due to its diverse biosynthetic functions. While some tumors can synthesize serine de novo, others are auxotrophic and therefore reliant on serine uptake. Importantly, despite several transporters being known to be capable of transporting serine, the transporters that mediate serine uptake in cancer cells are not known. Here, we characterize the amino acid transporter ASCT2 (SLC1A5) as a major contributor to serine uptake in cancer cells. ASCT2 is well known as a glutamine transporter in cancer, and our work demonstrates that serine and glutamine compete for uptake through ASCT2. We further show that ASCT2-mediated serine uptake is essential for purine nucleotide biosynthesis and that estrogen receptor α (ERα) promotes serine uptake by directly activating SLC1A5 transcription. Collectively, our work defines an additional important role for ASCT2 as a serine transporter in cancer and evaluates ASCT2 as a potential therapeutic target.